InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,156.36
(
0.56%
)
US TECH 100
17,509.40
(
0.52%
)
Dow Jones
38,724.38
(
0.13%
)
Brent Oil
83.65
(
0.63%
)
Bitcoin
63,514.61
(
-0.76%
)
Post# of 48316
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

hschlauch

Send PM Follow Ignore
Followers 19
Posts 334
Boards Moderated 0
Alias Born 07/25/2016

hschlauch

Re: Pazzo1212 post# 45705

Tuesday, 11/13/2018 3:31:58 PM

Tuesday, November 13, 2018 3:31:58 PM

Post# of 48316
These patients received just a single cycle of TAVO per protocol, not a full regimen. There may be others - like the two who went straight to pembro and responded - who went off protocol, but I wouldn't count on it. The point of OMS140 was to view immunologic responses with a single cycle. I don't think they will look at BORR for OMS140.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ONCSQ News
More ONCSQ News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!